Business Wire

Global Traumatic Brain Injury Assessment & Management Devices Market Research Report 2021-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Traumatic Brain Injury Assessment & Management Devices Market Share, Size, Trends, Industry Analysis Report, By Device, By Technique, By End-Use, By Region; Segment Forecast, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering.

The global traumatic brain injury assessment & management devices market size is expected to reach USD 5.56 Billion by 2028

Traumatic brain injuries are a major public health problem that causes a large number of cases per year around the world. Falls are one of the most common reasons for TBI patients to be admitted to the hospital, accompanied by motor vehicle accidents.

According to the CDC, 3.5 million people in the United States have a chronic TBI-related impairment. As a result, the market for TBI evaluation and management devices is expected to rise as the number of cases of TBIs rises due to an increase in traffic accidents and injuries.

Increased intracranial pressure occurs as the pressure inside the skull increases as a result of or as a result of brain injury. Intracranial pressure control systems and instruments aid in the monitoring of intracranial pressure, which can be a severe and life-threatening medical issue.

By pushing on important tissues and limiting blood flow into the brain, the pressure can cause damage to the brain and spinal cord. This segment’s growth has been aided by an increase in the number of cases of head injury and the prevalence of neurodegenerative disorders. Furthermore, growing public perception of head injuries, as well as technical advances, have helped the market growth for traumatic brain injury assessment & management devices.

Market participants operating in the traumatic brain injury assessment & management devices industry include BioDirection, Compumedics, Neural Analytics, Inc., Elekta AB, Natus Medical Incorporated, Integra Lifesciences, BrainScope, and Nihon Kohden Corporation.

Furthermore, industry players are expected to fuel the market growth for traumatic brain injury assessment & management devices during the forecast period by integrating emerging technologies and launching new products. In addition, several expansion strategies adopted by the players is likely to increase in the competitive rivalry in the market.

For instance, in February 2021, the US Food & Drug Administration has approved the marketing of a new product that is worn around the neck of athletes aged 13 and up during athletic activities to help protect the brain from the effects of repeated sub-concussive head impacts. The system can help to reduce the frequency of some brain changes linked to brain injury.

The traumatic brain injury assessment & management devices market report based device, technique, end-use, and region:

Traumatic Brain Injury Assessment & Management Devices, Devices Outlook (Revenue – USD Billion, 2016 – 2028)

  • Imaging Devices
  • Magnetic Resonance Imaging (MRI) Devices
  • X-Ray
  • Computed Tomography
  • Others
  • Monitoring Devices

Traumatic Brain Injury Assessment & Management Devices, Technique Outlook (Revenue – USD Billion, 2016 – 2028)

  • Partial Pressure of Oxygen in Brain Tissue (pBrO2)
  • Intracranial Pressure (ICP) Monitoring

Traumatic Brain Injury Assessment & Management Devices, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Hospitals
  • Diagnostic Centers
  • Others

Traumatic Brain Injury Assessment & Management Devices, Regional Outlook (Revenue – USD Billion, 2016 – 2028)

  • North America
  • US
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Companies Mentioned

  • BioDirection
  • Compumedics
  • Neural Analytics Inc.
  • Elekta AB
  • Natus Medical Incorporated
  • Integra Lifesciences
  • BrainScope
  • Nihon Kohden Corporation.

For more information about this report visit https://www.researchandmarkets.com/r/ttrrpj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker